Single or tandem autologous stem cell transplantation for treating Chinese patients with refractory/relapsed classical Hodgkin lymphoma

Abstract Background Autologous stem cell transplantation (ASCT) is the standard treatment strategy for refractory or relapsed classical Hodgkin lymphoma (R/R cHL). However, a single transplantation is insufficient to cure the disease because of unfavorable risk factors. Herein, we evaluated the outc...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Chen Zhang, Jili Deng, Yan Xie, Lan Mi, Weiping Liu, Xiaopei Wang, Linjun Zhao, Yuqin Song, Jun Zhu
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Wiley 2023-05-01
Edice:	Cancer Medicine
Témata:	refractory or relapsed classical Hodgkin lymphoma single autologous stem cell transplantation tandem autologous stem cell transplantation unfavorable risk
On-line přístup:	https://doi.org/10.1002/cam4.5765
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!